WBI Investments Inc. Sells 11,211 Shares of Innophos Holdings, Inc. (IPHS)

WBI Investments Inc. lessened its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 24.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,159 shares of the specialty chemicals company’s stock after selling 11,211 shares during the period. WBI Investments Inc.’s holdings in Innophos were worth $1,561,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in IPHS. Investment Counselors of Maryland LLC grew its position in shares of Innophos by 69.2% in the 2nd quarter. Investment Counselors of Maryland LLC now owns 471,896 shares of the specialty chemicals company’s stock valued at $22,462,000 after acquiring an additional 193,003 shares during the period. BlackRock Inc. grew its position in shares of Innophos by 6.8% in the 2nd quarter. BlackRock Inc. now owns 2,665,668 shares of the specialty chemicals company’s stock valued at $126,885,000 after acquiring an additional 170,407 shares during the period. Northpointe Capital LLC grew its position in shares of Innophos by 2,069.0% in the 3rd quarter. Northpointe Capital LLC now owns 169,140 shares of the specialty chemicals company’s stock valued at $7,510,000 after acquiring an additional 161,342 shares during the period. Deprince Race & Zollo Inc. grew its position in shares of Innophos by 30.1% in the 2nd quarter. Deprince Race & Zollo Inc. now owns 433,676 shares of the specialty chemicals company’s stock valued at $20,643,000 after acquiring an additional 100,304 shares during the period. Finally, Wells Fargo & Company MN grew its position in shares of Innophos by 31.0% in the 2nd quarter. Wells Fargo & Company MN now owns 238,344 shares of the specialty chemicals company’s stock valued at $11,345,000 after acquiring an additional 56,464 shares during the period. 93.92% of the stock is owned by institutional investors.

A number of research analysts have recently commented on the stock. BidaskClub downgraded shares of Innophos from a “buy” rating to a “hold” rating in a research report on Wednesday, July 25th. TheStreet downgraded shares of Innophos from a “b-” rating to a “c+” rating in a report on Thursday, August 23rd. ValuEngine downgraded shares of Innophos from a “hold” rating to a “sell” rating in a report on Friday, October 12th. Finally, Zacks Investment Research downgraded shares of Innophos from a “hold” rating to a “strong sell” rating in a report on Thursday, October 25th.

Shares of IPHS stock opened at $30.65 on Friday. The stock has a market cap of $600.99 million, a P/E ratio of 13.56 and a beta of 1.21. The company has a quick ratio of 1.34, a current ratio of 2.79 and a debt-to-equity ratio of 1.01. Innophos Holdings, Inc. has a 52 week low of $27.46 and a 52 week high of $50.40.

Innophos (NASDAQ:IPHS) last announced its earnings results on Thursday, November 1st. The specialty chemicals company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.01). The company had revenue of $196.93 million for the quarter, compared to the consensus estimate of $197.20 million. Innophos had a return on equity of 13.30% and a net margin of 2.49%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.78 EPS. On average, research analysts forecast that Innophos Holdings, Inc. will post 2.35 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Friday, November 16th will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 6.26%. The ex-dividend date of this dividend is Thursday, November 15th. Innophos’s payout ratio is 78.05%.

Innophos Company Profile

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Featured Article: Hedge Funds – How They Work For Investors

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply